Ascendis Pharma (ASND) Priced

Developing long-acting treatments for growth hormone deficiency.

Health Care - Biotechnology

IPO Performance
Latest Trade $27.63 -0.61 (-2.2%)
First Day Return 4.6%
Return from IPO 56.9%
 
Ascendis Pharma IPO News more
  • .
IPO Data
IPO File Date 12/18/2014
Offer Price $18.00
Price Range $16.00 - $18.00
Offer Shares (mm) 6.0
Deal Size ($mm) 108
 
IPO Data
IPO Date 01/27/2015
Offer Price $18.00
Price Range $16.00 - $18.00
Offer Shares (mm) 6.0
Deal Size ($mm) $108
 
Underwriters
more
Business Overview
Developing long-acting treatments for growth hormone deficiency.
Developing long-acting treatments for growth hormone deficiency.
more
Company Data
Headquarters Hellerup, , Denmark
Founded 2006
Employees 55
Website www.ascendispharma.com
 

Performance vs. IPO Index (IPOUSA)